|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 |
| (11) | Patento numeris | 3169784 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15822399.0 |
| Europos patento paraiškos padavimo data | 2015-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/040517 |
| Data | 2015-07-15 |
| (87) | Numeris | WO 2016/011123 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201462025164 P | 2014-07-16 | US |
| (72) |
WEILER, Jan, US
CHUTKOW, William, US
BARYZA, Jeremy Lee, US
KRUEGER, Andrew, US
ZHAO, Junping, US
|
| (73) |
Arrowhead Pharmaceuticals, Inc.,
225 South Lake Avenue Suite 1050, Pasadena, CA 91101,
US
|
| (54) | RNAI COMPOSITIONS TO TREAT APOC3-RELATED DISEASES |
| RNAI COMPOSITIONS TO TREAT APOC3-RELATED DISEASES |